Provided is an alicyclic epoxy compound product used in applications for forming a cured product excellent in transparency and heat resistance. An alicyclic epoxy compound product of the present disclosure has a purity of a compound represented by Formula (1) of 85 wt. % or greater; and a total content of a compound represented by Formula (a) and a compound represented by Formula (b) of 0.5 wt. % or less, where X represents a single bond or a linking group. The alicyclic epoxy compound product of the present disclosure can be produced through subjecting a compound represented by Formula (1″) to a dehydration reaction to obtain a compound represented by Formula (1′), and reacting the resulting compound represented by Formula (1′) with an organic peracid.

##STR00001##

Provided is an alicyclic epoxy compound product used in applications for forming a cured product excellent in transparency and heat resistance. An alicyclic epoxy compound product of the present disclosure has a purity of a compound represented by Formula (1) of 85 wt. % or greater; and a total content of a compound represented by Formula (a) and a compound represented by Formula (b) of 0.5 wt. % or less, where X represents a single bond or a linking group. The alicyclic epoxy compound product of the present disclosure can be produced through subjecting a compound represented by Formula (1″) to a dehydration reaction to obtain a compound represented by Formula (1′), and reacting the resulting compound represented by Formula (1′) with an organic peracid.

##STR00001##

The present disclosure relates to gel compositions comprising the reaction product of at least one epoxidized molecule and at least one crosslinker, which has the benefit of compatibility with personal care components and the resulting personal care formulations. The present disclosure also relates to methods of preparing gel compositions.

The present disclosure relates to gel compositions comprising the reaction product of at least one epoxidized molecule and at least one crosslinker, which has the benefit of compatibility with personal care components and the resulting personal care formulations. The present disclosure also relates to methods of preparing gel compositions.

The present disclosure, in at least certain embodiments, is directed to shikimate (shikimic acid) analogues and compositions thereof, devices and kits which contain the shikimate analogues or compositions thereof, and methods of use of the compounds and compositions for treating and neutralizing irritant or odoriferous compounds on animate or inanimate surfaces or in atmospheres.

The present disclosure, in at least certain embodiments, is directed to shikimate (shikimic acid) analogues and compositions thereof, devices and kits which contain the shikimate analogues or compositions thereof, and methods of use of the compounds and compositions for treating and neutralizing irritant or odoriferous compounds on animate or inanimate surfaces or in atmospheres.

An improved process for the recovery of high-purity ethylene-oxide water feed streams to EO purification and MEG reaction units when both are operating in EO plants that incorporate EO Stripper bypass technology, by installing a second lights stripper to exclusively degasify the diluted EO feed to the MEG reactor, thus permitting the use of additional bypassed (gasified) EO absorbate as the diluent and resulting in a substantial increase in the total amount of EO absorbate that can bypass the EO Stripper.

An improved process for the recovery of high-purity ethylene-oxide water feed streams to EO purification and MEG reaction units when both are operating in EO plants that incorporate EO Stripper bypass technology, by installing a second lights stripper to exclusively degasify the diluted EO feed to the MEG reactor, thus permitting the use of additional bypassed (gasified) EO absorbate as the diluent and resulting in a substantial increase in the total amount of EO absorbate that can bypass the EO Stripper.

An ethylene oxide (EO) production process comprising (a) introducing a first reactant mixture (C.sub.2H.sub.6, O.sub.2) to a first reactor to produce a first effluent stream (C.sub.2H.sub.4, C.sub.2H.sub.6, O.sub.2); (b) introducing a second reactant mixture to a second reactor to produce a second effluent stream (EO, C.sub.2H.sub.4, C.sub.2H.sub.6, O.sub.2); wherein the second reactant mixture comprises at least a portion of first effluent stream; (c) separating the second effluent stream into an EO product stream (EO) and recycle stream (C.sub.2H.sub.4, C.sub.2H.sub.6, O.sub.2); wherein ethylene is not separated from recycle stream and/or first effluent stream; and (d) recycling a first portion of recycle stream to the first reactor, and a second portion of recycle stream to the second reactor; wherein recycle split ratio <0.6; and wherein recycle split ratio is defined as ratio of volumetric flowrate of first portion of recycle stream divided by the sum of volumetric flowrates of first portion and second portion of recycle stream.

Methods for the preparation of the following compound are disclosed. ##STR00001##
The compound can be incorporated into pharmaceutical formulations, including tablets and such tablets can be used for treating cholestatic liver diseases.